BOULDER, Colo., Oct 24, 2005 /PRNewswire-FirstCall via COMTEX News Network/ -- Array BioPharma Inc.
(Nasdaq: ARRY) will report financial results for the first quarter of fiscal
2006 on Monday, October 31, 2005, at 4:30 p.m. eastern time and hold a
conference call on Tuesday, November 1, 2005, at 9:00 a.m. eastern time.
Robert E. Conway, Chief Executive Officer, and Michael Carruthers, Chief
Financial Officer, will lead the call.
Conference Call Information
Date: Tuesday, November 1, 2005
Time: 9:00 a.m. eastern time
Toll-Free: (800) 500-0177
Toll: (719) 457-2679
Pass Code: 9419226
Web Cast: www.arraybiopharma.com
There will be a replay of the conference call for one week, which can be
accessed in the United States by dialing toll-free (888) 203-1112, and outside
the United States (719) 457-0820. The access code is 9419226. Replay of the
call will also be available as a web cast on Array's web site at
www.arraybiopharma.com.
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule drugs
to treat life threatening and debilitating diseases. Our proprietary drug
development pipeline is focused on the treatment of cancer and inflammatory
disease and includes clinical candidates that are designed to regulate
therapeutically important targets. In addition, leading pharmaceutical and
biotechnology companies access Array's drug discovery technologies and
expertise through collaborations to design, create, optimize and evaluate drug
candidates across a broad range of therapeutic areas. For more information on
Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.
Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, thaugeto@arraybiopharma.com
